Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Phenoxybenzamine Hydrochloride

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 37,980Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Enforcement Report - Week of February 14, 2024
    Enforcement Report - Week of February 14, 2024

    14 Feb 2024

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-14-2024-75684.pdf

    FDA
    14 Feb 2024
    Share Share
    Rising's Generic (Phenoxybenzamine Hydrochloride) Receives Approval in the U.S.
    Rising's Generic (Phenoxybenzamine Hydrochloride) Receives Approval in the U.S.

    20 Jun 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204551

    FDA
    20 Jun 2023
    Share Share
    Aurobindo's Generic Phenoxybenzamine HCL Receives Receives Approval in the U.S.
    Aurobindo's Generic Phenoxybenzamine HCL Receives Receives Approval in the U.S.

    08 May 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215600

    FDA
    08 May 2023
    Share Share
    Novitium's Generic Phenoxybenzamine Hydrochloride Receives Approval in the U.S.
    Novitium's Generic Phenoxybenzamine Hydrochloride Receives Approval in the U.S.

    19 Jul 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215042

    FDA
    19 Jul 2022
    Share Share
    Par's Generic Phenoxybenzamine Hcl Receives Approval In US
    Par's Generic Phenoxybenzamine Hcl Receives Approval In US

    24 Jan 2017

    // FDA

    http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204522

    FDA
    24 Jan 2017
    Share Share
    Concordia Healthcare to Buy Some Assets of Covis Pharma for $1.2 Billion
    Concordia Healthcare to Buy Some Assets of Covis Pharma for $1.2 Billion

    10 Mar 2015

    // Sneha Banerjee REUTERS

    http://www.reuters.com/article/2015/03/09/us-covis-phrama-m-a-concordia-hlthcr-idUSKBN0M50XS20150309

    Sneha Banerjee REUTERS
    10 Mar 2015
    Share Share